Browse Category

Stock Market 29 June 2026 - 30 June 2026

Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Abivax (NASDAQ:ABVX) ADS gain $2.3B after obefazimod safety news; Paris session yet to start

Abivax S.A. is set for a lagged Paris opening after its U.S. ADS jumped in after-hours trading. Investors reacted to new clinical data on obefazimod, Abivax’s ulcerative colitis drug. The latest news hits late, but the drop earlier this month wasn’t about whether the drug works. It was about the potential cancer risk and what that could mean for the drug’s label.
Concentrix (NASDAQ:CNXC) stock sinks on Q2 guidance cut as cash flow rises

Concentrix (NASDAQ:CNXC) stock sinks on Q2 guidance cut as cash flow rises

Concentrix Corporation lost more than a fifth of its market value in after-hours trading on Monday after the customer-experience services company gave a soft outlook, even as its second-quarter cash flow improved. The stock last traded at $19.55, down 22.5%, after closing up 0.9% at $25.23; after-hours volume was 1.07 million shares, MarketWatch data showed.
Rivian (NASDAQ:RIVN) gains as Russell growth index inclusion hits R2 ramp milestone

Rivian (NASDAQ:RIVN) gains as Russell growth index inclusion hits R2 ramp milestone

Rivian Automotive, Inc. jumped 7.55% to finish at $16.81 on Monday after S&P Capital IQ confirmed the EV maker is going into the Russell 3000E Growth Benchmark. The stock closed near where it traded when the R2 SUV started shipping to customers earlier this month. But Monday’s move was more about index flows and a bounce in EV names than just Rivian itself, traders said.
Rocket Lab-Iridium deal puts cash-flow satellites in focus for space stocks in June 2026

Rocket Lab-Iridium deal puts cash-flow satellites in focus for space stocks in June 2026

Space and satellite stocks faced a tougher test this Monday than the SpaceX-driven rally that kicked off June, as investors started to focus on networks and contracts over just launch schedules. Rocket Lab Corporation said it will buy Iridium Communications Inc. in a deal valued at about $8 billion. The deal brings Rocket Lab access to L-band spectrum, over 2.55 million subscribers and $495 million in 2025 operational EBITDA to fold into its launch and spacecraft operations.
Palantir (NASDAQ:PLTR) rises after NVIDIA (NASDAQ:NVDA) AI tie-up, but trades at about 39x sales forecast

Palantir (NASDAQ:PLTR) rises after NVIDIA (NASDAQ:NVDA) AI tie-up, but trades at about 39x sales forecast

Palantir Technologies Inc. gained 2.4% to $115.70 late Monday after partnering with NVIDIA Corporation on an AI engine for U.S. government and critical infrastructure clients. Investors bought in: some $5.1 billion worth of Palantir shares traded, and the $2.74 gain tacked on around $7.0 billion in market cap. That’s close to 92% of Palantir’s 2026 revenue guidance midpoint.
AI shares June 2026: memory and power plays go different ways

AI shares June 2026: memory and power plays go different ways

U.S. AI stocks closed out June showing a more defined split than earlier in the month. On one side were suppliers with signed AI orders. On the other, big spenders and software names trading at high multiples. NVIDIA, Broadcom, Micron Technology and Vertiv gave investors new operating numbers tied to their AI business. Microsoft, Alphabet, Amazon.com and Meta Platforms remained key to demand, but the market focus moved in June to how the spending gets funded and what kind of payback investors can expect.
Nasdaq bounce hides thin megacap recovery as US stocks end

Nasdaq bounce hides thin megacap recovery as US stocks end

U.S. stocks climbed Monday, but the close didn’t fully back up the day’s upbeat numbers. The Nasdaq led gains, S&P 500 rose over 1%, and the Dow crossed 52,000. Even so, there weren’t many fresh highs and breadth stayed moderate. The move seemed more about big-cap names bouncing than a real broad rally heading into the end of the quarter.
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.